4-(3,4-dihydro-2H-chromen-4-yloxy)-N-(2-hydroxyethyl)-N,N,1,2-trimethyl-1H-benzimidazole-6-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 4-(3,4-dihydro-2H-chromen-4-yloxy)-N-(2-hydroxyethyl)-N,N,1,2-trimethyl-1H-benzimidazole-6-carboxamide
• 英文别名: 4-(3,4-Dihydro-2H-chromen-4-yloxy)-N-(2-hydroxyethyl)-N,1,2-trimethyl-1H-benzimidazole-6-carboxamide；7-(3,4-dihydro-2H-chromen-4-yloxy)-N-(2-hydroxyethyl)-N,2,3-trimethylbenzimidazole-5-carboxamide
• 化学式: C₂₂H₂₅N₃O₄
• 分子量: 395.458
• InChiKey: DIEQFGBCRUNAOJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  76.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  4-chloro-3,4-dihydro-2H-chromene 在 甲醇 、 lithium hydroxide 、 水 、 sodium hydride 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 43.83h， 生成 4-(3,4-dihydro-2H-chromen-4-yloxy)-N-(2-hydroxyethyl)-N,N,1,2-trimethyl-1H-benzimidazole-6-carboxamide
  参考文献：
  名称：

  WO2006/134460

  摘要：

  公开号：

文献信息

• Chromane Substituted Benzimidazole Derivatives as Acid Pump Antagonists
  申请人：Koike Hiroki

  公开号：US20080214519A1

  公开（公告）日：2008-09-04

  This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, B, X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 , R 7 , R 8 and R 9 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of Helicobacter pylori, dyspepsia, functional dyspepsia, Zollinger-Ellison syndrome, non-erosive reflux disease (NERD), visceral pain, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma.

  本发明涉及式(I)的化合物或其药学上可接受的盐，其中：A、B、X、R1、R2、R3、R4、R5和R6、R7、R8和R9分别如本文所述或其药学上可接受的盐，以及包含这种化合物的组合物以及在治疗由酸泵拮抗活性介导的疾病，如但不限于胃肠疾病、胃食管疾病、胃食管反流病（GERD）、消化性溃疡、胃溃疡、十二指肠溃疡、NSAID诱导性溃疡、胃炎、幽门螺杆菌感染、消化不良、功能性消化不良、佐林格-埃里森综合症、非侵蚀性反流性疾病（NERD）、内脏疼痛、心口灼热、恶心、食管炎、吞咽困难、多口水、气道障碍或哮喘等疾病中使用这种化合物的用途。
• Chromane substituted benzimidazole derivatives as acid pump antagonists
  申请人：RaQualia Pharma Inc.

  公开号：US07718809B2

  公开（公告）日：2010-05-18

  This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, B, X, R1, R2, R3, R4, R5 and R6, R7, R8 and R9 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of Helicobacter pylori, dyspepsia, functional dyspepsia, Zollinger-Ellison syndrome, non-erosive reflux disease (NERD), visceral pain, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma.

  本发明涉及公式(I)的化合物或其药学上可接受的盐，其中：A、B、X、R1、R2、R3、R4、R5和R6、R7、R8和R9各自如本文所述或其药学上可接受的盐，并且包含这种化合物的组合物以及在治疗由酸泵拮抗活性介导的疾病中使用这种化合物，例如但不限于胃肠道疾病、胃食管疾病、胃食管反流病（GERD）、消化性溃疡、胃溃疡、十二指肠溃疡、NSAID诱导性溃疡、胃炎、幽门螺杆菌感染、消化不良、功能性消化不良、佐林格-埃里森综合征、非侵蚀性反流病（NERD）、内脏疼痛、心灼热、恶心、食管炎、吞咽困难、过度流涎、气道疾病或哮喘。
• CHROMANE SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ACID PUMP ANTAGONISTS
  申请人：RaQualia Pharma Inc

  公开号：EP1893197B1

  公开（公告）日：2009-09-09
• US7718809B2
  申请人：——

  公开号：US7718809B2

  公开（公告）日：2010-05-18
• WO2006/134460
  申请人：——

  公开号：——

  公开（公告）日：——